
Investors must take note of UroGen Pharma Ltd’s (URGN) performance last week, which was -4.64%.
UroGen Pharma Ltd (NASDAQ: URGN) kicked off on Monday, down -4.84% from the previous trading day, before settling in for the closing price of $19.44.
UroGen Pharma Ltd (NASDAQ: URGN) kicked off on Monday, down -4.84% from the previous trading day, before settling in for the closing price of $19.44.
On Friday, UroGen Pharma Ltd (NASDAQ: URGN) was -4.55% drop from the session before settling in for the closing price of $18.59. A 52-week range
On Tuesday, UroGen Pharma Ltd (NASDAQ: URGN) was 4.23% up from the session before settling in for the closing price of $19.88. A 52-week range
UroGen Pharma Ltd (NASDAQ: URGN) on Friday, soared 5.28% from the previous trading day, before settling in for the closing price of $18.0. Within the
As on Wednesday, UroGen Pharma Ltd (NASDAQ: URGN) got off with the flyer as it spiked 10.02% to $18.66, before settling in for the price
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.